GlucoTrack, Inc. (GCTK)

GlucoTrack Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0	0	0	0	0	0.21
Revenue Growth (YoY)	-	-	-	-	-	378.29%
Gross Profit	0	0	0	0	0	0.21
Selling, General & Admin	2.01	2.4	2.47	2.23	1.6	2.11
Research & Development	5.58	4.7	1.97	1.81	1.53	1.61
Other Operating Expenses	0	0	0.01	0.05	0	0
Operating Expenses	7.59	7.1	4.45	4.09	3.13	3.71
Operating Income	-7.59	-7.1	-4.45	-4.09	-3.13	-3.51
Interest Expense / Income	-0.03	-0.01	-0.01	-0.03	-0.1	0.01
Other Expense / Income	-	-	-	-	-0.34	-
Pretax Income	-7.56	-7.1	-4.44	-4.07	-2.7	-3.52
Net Income	-7.56	-7.1	-4.44	-4.07	-2.7	-3.52
Shares Outstanding (Basic)	5	4	3	3	3	2
Shares Outstanding (Diluted)	5	4	3	3	3	2
Shares Change	60.99%	34.16%	0.15%	2.46%	26.53%	1745.09%
EPS (Basic)	-2.05	-1.90	-1.45	-1.30	-0.95	-1.30
EPS (Diluted)	-2.05	-1.90	-1.45	-1.30	-0.95	-1.30
Free Cash Flow	-8.25	-6.56	-3.73	-3.77	-3.55	-3.92
Free Cash Flow Per Share	-1.65	-1.58	-1.21	-1.22	-1.18	-1.65
Gross Margin	-	-	-	-	-	100.00%
Operating Margin	-	-	-	-	-	-1685.58%
Profit Margin	-	-	-	-	-	-1690.38%
Free Cash Flow Margin	-	-	-	-	-	-1885.58%
EBITDA	-7.58	-7.09	-4.42	-4.05	-2.75	-3.46
EBITDA Margin	-	-	-	-	-	-1661.06%
Depreciation & Amortization	0.01	0.01	0.02	0.04	0.05	0.05
EBIT	-7.59	-7.1	-4.45	-4.09	-2.79	-3.51
EBIT Margin	-	-	-	-	-	-1685.58%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).